Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

SEBI REJECTS SUN PHARMA'S OFFER FOR GUJARAT LYKA

Article Abstract:

The application of Sun Pharmaceutical Industries Ltd (SPIL) for an exemption from the takeover code for acquiring 20.17 percent stake in Gujarat Lyka Organics Ltd (GLO) has been rejected by the Securities and Exchange Board of India (Sebi). SPIL had proposed to acquire 32,07,500 equity shares (20.17 percent stake) in GLO from Virtuous Finance Ltd (VFL), Jeevanrekha Investrade Pvt Ltd (JIPL) and Package Investrade Pvt Ltd (PIPL). VFL, JIPL and PIPL are investment companies promoted by SPIL's promoter and associates. Sebi has rejected the application since the applicants had failed to prove that they were companies coming under the definition of group, as defined in Sebi's regulations. (ag)

Comment:

Request for an exemption from takeover code for acquiring 20.17% stake in Gujarat Lyka Organics is rejected

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Sun Pharmaceutical Industries Ltd., Gujarat Lyka Organics Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


SUN PHARMA EYES PLETHICO, BEGINS TALKS FOR TAKEOVER

Article Abstract:

Sun Pharmaceuticals has commenced preliminary takeover negotiations with Plethico Pharmaceuticals, Indore. Plethico is a producer of anti-tuberculosis and anti-malarial drugs. It also produces methi-based products used in the treatment of cholesterol, and a doxycycline brand. Plethico has two production facilities at Indore. Sun posted a net profit of Rs56.12 crore during 1997-98 (Rs49.07 crore in 1996-97). (ag)

Comment:

Commences preliminary takeover negotiations with Plethico Pharmaceuticals, producer of anti-tuberculosis & anti-malarial drugs

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Antimalarial & Antifungal Preps, Plethico Pharmaceuticals, Sun Pharmaceuticals (India) Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


SHALIL SHROFF UPS STAKE IN PUNJAB CHEMICALS TO 10%

Article Abstract:

Mr Shalil Shroff, one of the promoters of Punjab Chemicals and Pharmaceuticals Limited, has increased his stake in the company by 2 percent. This was done by acquiring the 1.88 percent stake held by Transpek Industry of Baroda and 0.12 percent from the market. Mr Shroff's stake in the Rs2.16 crore equity capital in Punjab Chemicals and Pharmaceuticals has now increased to almost 10 percent. (khr)

Comment:

Sells its 1.88% stake in Punjab Chemicals & Pharmaceuticals to Mr Shalil Shroff

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Punjab Chemicals and Pharmaceuticals Ltd., Transpek Industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drugs, India, Article
Similar abstracts:
  • Abstracts: CASHING IN ON CASHEW GLOBAL SHORTAGE REPORTS PUSH CASHEW PRICES TO RECORD HIGH CASHEW NYET
  • Abstracts: TELCO JOINS ASHOK LEYLAND, UPS PRICES ASHOK LEYLAND AGM TO SEE NEW MODELS ASHOK LEYLAND GAINING GROUND IN TELCO'S EASTERN STRONGHOLD
  • Abstracts: CARE TO OFFER 5-10 PERCENT EQUITY STAKE TO FITCH IBCA. CHASE BUYS OUT NATWEST's 20 PC STAKE IN HDFC BANK CRISIL SCRIP ON HIGH
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.